Florence Gaven

CNRS, Institut de Génomique Fonctionnelle, Montpellier

Affiliated withInstitut de Génomique Fonctionnelle, Montpellier U661, Montpellier Universités de Montpellier

Research Area

Biography

Florence Gaven has not added Biography.
If you are Florence Gaven and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 65	2014

Other Publications

Article	Year
Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 12151600	2002
Confinement but not microgravity alters NMDA NR1 receptor expression in rat inner ear ganglia. Neuroreport\| PubMed ID: 12858054	2003
Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 14691258	2004
Palmitoylation of the 5-hydroxytryptamine4a receptor regulates receptor phosphorylation, desensitization, and beta-arrestin-mediated endocytosis. Molecular pharmacology\| PubMed ID: 15689570	2005
Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements. The Journal of biological chemistry\| PubMed ID: 15919661	2005
5-hydroxytryptamine 4 receptor activation of the extracellular signal-regulated kinase pathway depends on Src activation but not on G protein or beta-arrestin signaling. Molecular biology of the cell\| PubMed ID: 17377064	2007
Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists. Journal of medicinal chemistry\| PubMed ID: 17602546	2007
Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors. Molecular pharmacology\| PubMed ID: 19168624	2009
Beta-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling. The EMBO journal\| PubMed ID: 19661922	2009
G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient. The Journal of biological chemistry\| PubMed ID: 21247891	2011
Gα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 22539851	2012
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO molecular medicine\| PubMed ID: 23027611	2012
Pharmacological profile of engineered 5-HT₄ receptors and identification of 5-HT₄ receptor-biased ligands. Brain research\| PubMed ID: 23148949	2013
5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10. ACS chemical neuroscience\| PubMed ID: 23336052	2013
Serotonin type 4 receptor dimers. Methods in cell biology\| PubMed ID: 24143975	2013
Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease. Frontiers in aging neuroscience\| PubMed ID: 24399967	2013
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 25157130	2014